We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WOR icon
2601
Worthington Enterprises
WOR
$2.79B
– –
-258
Closed -$5
WTTR icon
2602
Select Water Solutions
WTTR
$2.34B
$0 ﹤0.01%
+83
New +$670
X
2603
DELISTED
US Steel
X
$0 ﹤0.01%
32
– –
XNET
2604
Xunlei
XNET
$369M
$0 ﹤0.01%
107
– –
XPRO icon
2605
Expro Ltd
XPRO
$1.78B
– –
-2
Closed –
YRD
2606
Yiren Digital
YRD
$103M
$0 ﹤0.01%
54
– –
ZG icon
2607
Zillow
ZG
$7.32B
$0 ﹤0.01%
10
– –
PRKS icon
2608
United Parks & Resorts
PRKS
$2.12B
– –
-57
Closed -$1
TECX
2609
Tectonic Therapeutic
TECX
$578M
– –
-35
Closed -$6
AAMI
2610
Acadian Asset Management
AAMI
$2.95B
– –
-624
Closed -$6
VIVS
2611
VivoSim Labs
VIVS
$1.36M
$0 ﹤0.01%
1
– –
INFN
2612
DELISTED
Infinera Corporation Common Stock
INFN
– –
-264
Closed -$1
SIX
2613
DELISTED
Six Flags Entertainment Corp.
SIX
– –
-658
Closed -$33
AYX
2614
DELISTED
Alteryx Inc
AYX
– –
-348
Closed -$37
NSTG
2615
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-79
Closed -$1
ARAV
2616
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-1,455
Closed -$10
MRTX
2617
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-75
Closed -$5
CEQP
2618
DELISTED
Crestwood Equity Partners LP
CEQP
$0 ﹤0.01%
25
– –
FRGI
2619
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$0 ﹤0.01%
73
– –
RAD
2620
DELISTED
Rite Aid Corporation
RAD
$0 ﹤0.01%
38
– –
ZYNE
2621
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$0 ﹤0.01%
50
– –
CIH
2622
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$0 ﹤0.01%
199
– –
ATCO
2623
DELISTED
Atlas Corp.
ATCO
– –
-5,719
Closed -$60
LCI
2624
DELISTED
Lannett Company, Inc.
LCI
$0 ﹤0.01%
18
– –
PRTY
2625
DELISTED
Party City Holdco Inc.
PRTY
– –
-2,130,660
Closed -$12.2K
103 104
105
106 107

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.